First, we found FBXO22 mRNA was highly expressed in both lung squamous cell carcinoma and lung adenocarcinoma in The Cancer Genome Atlas (TCGA) database and the cohort of GSE31210 lung cancer patients17 (Fig. 1a). This evidence concerns the gene FBXO22 and lung adenocarcinoma.